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Abstract
Plantar warts caused by human papilloma virus (HPV)
may be challenging to treat when conventional
modalities fail. We report a case of severely recalcitrant
plantar warts, successfully treated with oral acitretin
and topical 40% urea cream.

Keywords: verruca vulgaris, acitretin, urea cream,
recalcitrant plantar warts

Introduction
Verrucae vulgaris are caused by human papilloma virus
(HPV) strains 1, 2, 4, 7, 57 [1] and have a prevalence of
approximately 10% [2]. Although verrucae are often
self-limited, palmoplantar warts can be particularly
recalcitrant to multiple treatment modalities and
symptomatic when located periungually or on the
palmar and plantar surfaces. We report a 33-year-old
man with recalcitrant plantar warts with a significant
response to a combination of oral acitretin and 40%
urea cream.

Figure 1. Pre-treatment showing presence of warts over soles

Case Synopsis
We report a 33-year-old man with a 3-4-year history of
recalcitrant, diffuse verruca vulgaris over the bilateral
plantar feet and toes who required treatment with
daily oral acitretin 25 mg and twice daily urea cream
40% for symptomatic and clinical control (Figure 1).
After 1 month of this new treatment regimen, his
multiple, thick, verrucous papules were significantly
thinner (Figure 2). At the end of 4 months he
experienced near complete clinical clearance.
Additionally pain with ambulation that had been
present for years had completely resolved.

Figure 2. Post-treatment picture showing markedly reduced size
of the warts.

The patient had previously failed cryotherapy,
cimetidine, and ‘formaldehyde with scraping.’ He
was also unable to tolerate intralesional candidin
injections owing to pain. He had no history of
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constitutional symptoms, immunosuppression, risk
for human immunodeficiency virus, or family history
of warts or immunodeficiencies,
Owing to severe pain with walking, systemic
treatment with daily oral acitretin was initiated in
January 2016 in combination with urea cream 40%
twice daily. Baseline routine laboratory evaluations
including liver function tests and lipid profile
were notable for mildly elevated triglycerides and
cholesterol. The patient’s hypertension, was being
monitored and treated by the patient’s primary
care physician. The only side effect of acitretin and
urea cream was dryness, controlled with liberal
moisturizing. Liver function tests remained within
normal limits and lipid profile was unchanged during
the treatment period.

Case Discussion
Treatment of viral warts can be challenging in the
face of recalcitrant lesions. Plantar warts can be
associated with significant pain and may therefore
interfere with activities of daily living.
Previous case reports in immunocompetent patients
have demonstrated improvements in recalcitrant
warts with acitretin. Choi et al. reported significant
improvement after 2 months of 1 mg/kg/day
acitretin in a 25-year old man with multiple warts on
the bilateral hands [3]. Although after discontinuing
acitretin the warts recurred, improvement was
again seen after restarting treatment with acitretin
[3]. Another report describes successful clearance
of long-standing periungual warts in a 46-year-old
woman after with a three-month course of acitretin,
25 mg daily, followed by every other day dosing.
Clinical remission was maintained 6 months after
discontinuation of treatment [4].
Recalcitrant warts on the scalp and beard areas,
resistant to conventional treatments have been
successfully treated with acitretin 0.5mg/kg/day for 3
months in combination with cryotherapy during the
first month, with improvement observed as early as
four weeks. Clearance was maintained 5 months after
stopping acitretin [5]. In another report a 20-year old
man with warts on face, palm, and left extremity
present for a duration of 6-years experienced
complete clearance of his lesions with acitretin 0.5

mg/kg/day continued for 3 months. The patient was
followed-up for 6 months after treatment with no
recurrence of lesions [6]. Another report documented
significant regression in wart size at 1 month and
complete flattening after 3 months in a 32-year-old
man with multiple warts on his hands, fingers, and
periungual area after treatment with acitretin 0.3
mg/kg/day. There was no recurrence 3 months after
stopping treatment [1].
Oral acitretin has been also been successful in
treating giant condyloma acuminatum, giant
warts in an immunocompromised patient, and
epidermodysplasia verruciformis, an autosomal
recessive disorder marked by widespread HPV
infection [12-15].
The side effect profiles of acitretin among these cases
are mild and include xerosis and chelitis, without
clinically significant laboratory abnormalities or
other side effects. Selection of appropriate patients
for treatment with acitretin is also important. In
particular, one should avoid this medication in
women of childbearing potential and in those with
other medical co-morbidities such as mood disorders
and alcoholism.
The efficacy of retinoid in wart therapy is believed to
be related to their influence on the regulation of cell
growth and differentiation with resulting inhibition
of viral replication and assembly within infected
cells [3, 9]. An inverse relationship between retinoid
concentration and level of HPV DNA supports the
role of retinoids in inhibition of viral replication [7].
Retinoids are not only potent immunomodulators
[8], but also have apoptotic activity, which likely
contributes to wart clearance [10]. Whereas topical
vitamin A (i.e. tretinoin) also can be effective for warts
[11], oral therapy was preferred in our patient owing
to significant wart thickness.

Conclusion
Plantar warts may be challenging to treat with
traditional therapies; persistent, symptomatic warts
may require alternative approaches to treatment.
Acitretin is a promising therapeutic option for
symptomatic viral warts recalcitrant to other
conventional treatment modalities among certain
patient populations.
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Supplement
Table 1: Previously reported successful treatment of warts with acitretin.
2011

Proietti et al

-Acitretin in common warts over the dorsal hands and periungually.
-Acitretin used for 12 weeks with complete resolution by 8 weeks.

2011

Kalidayan et al

-Complete resolution of scalp warts with acitretin 0.5mg/kg/once daily and cryotherapy.
-Response achieved after 4 weeks.
-Acitretin continued for 2 additional months.

2011

El-Khayat et al

-Acitretin resulting in complete clearance of periungual warts which did not respond
after 10 years of other treatments.

2008

Krupa shankar et al

-Warts on face, palms and lower limbs responding to acitretin 0.5mg/kg/day,
-No recurrence 6 months after treatment.

2006

Choi at al

-Acitretin 1 mg/kg/day with regression of recalcitrant warts on hands in 1 month, continued treatment for 2 additional months,
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